Literature DB >> 31326272

Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

Ning Jia1, Roger Jones2, George Sukenick3, Dinshaw J Patel4.   

Abstract

Target RNA binding to crRNA-bound type III-A CRISPR-Cas multi-subunit Csm surveillance complexes activates cyclic-oligoadenylate (cAn) formation from ATP subunits positioned within the composite pair of Palm domain pockets of the Csm1 subunit. The generated cAn second messenger in turn targets the CARF domain of trans-acting RNase Csm6, triggering its HEPN domain-based RNase activity. We have undertaken cryo-EM studies on multi-subunit Thermococcus onnurineus Csm effector ternary complexes, as well as X-ray studies on Csm1-Csm4 cassette, both bound to substrate (AMPPNP), intermediates (pppAn), and products (cAn), to decipher mechanistic aspects of cAn formation and release. A network of intermolecular hydrogen bond alignments accounts for the observed adenosine specificity, with ligand positioning dictating formation of linear pppAn intermediates and subsequent cAn formation by cyclization. We combine our structural results with published functional studies to highlight mechanistic insights into the role of the Csm effector complex in mediating the cAn signaling pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP conversion into pppA(n) intermediates and cA(n) products; adenosine recognition specificity; ligand positioning in composite Palm pocket; mechanistic insights into cA(4) formation and release; type III-A CRISPR-Cas Csm

Mesh:

Substances:

Year:  2019        PMID: 31326272      PMCID: PMC6731140          DOI: 10.1016/j.molcel.2019.06.013

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

2.  Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Authors:  Ning Jia; Charlie Y Mo; Chongyuan Wang; Edward T Eng; Luciano A Marraffini; Dinshaw J Patel
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

3.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

4.  A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.

Authors:  Wenyuan Han; Stefano Stella; Yan Zhang; Tong Guo; Karolina Sulek; Li Peng-Lundgren; Guillermo Montoya; Qunxin She
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

Review 5.  Diversity, classification and evolution of CRISPR-Cas systems.

Authors:  Eugene V Koonin; Kira S Makarova; Feng Zhang
Journal:  Curr Opin Microbiol       Date:  2017-06-09       Impact factor: 7.934

Review 6.  Conformational regulation of CRISPR-associated nucleases.

Authors:  Ryan N Jackson; Paul Bg van Erp; Samuel H Sternberg; Blake Wiedenheft
Journal:  Curr Opin Microbiol       Date:  2017-06-21       Impact factor: 7.934

7.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

8.  Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase.

Authors:  Pu Gao; Manuel Ascano; Yang Wu; Winfried Barchet; Barbara L Gaffney; Thomas Zillinger; Artem A Serganov; Yizhou Liu; Roger A Jones; Gunther Hartmann; Thomas Tuschl; Dinshaw J Patel
Journal:  Cell       Date:  2013-05-03       Impact factor: 41.582

9.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs.

Authors:  Alexis Rohou; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2015-08-13       Impact factor: 2.867

10.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex.

Authors:  Michael A Estrella; Fang-Ting Kuo; Scott Bailey
Journal:  Genes Dev       Date:  2016-02-04       Impact factor: 11.361

View more
  12 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

Review 2.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

Review 3.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

4.  Type III-A CRISPR systems as a versatile gene knockdown technology.

Authors:  Walter T Woodside; Nikita Vantsev; Ryan J Catchpole; Sandra C Garrett; Sara Olson; Brenton R Graveley; Michael P Terns
Journal:  RNA       Date:  2022-05-26       Impact factor: 5.636

Review 5.  CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.

Authors:  Zhenxiao Yu; Suping Jiang; Yuan Wang; Xuhui Tian; Pengpeng Zhao; Jianan Xu; Mingxia Feng; Qunxin She
Journal:  Sci China Life Sci       Date:  2020-10-29       Impact factor: 6.038

6.  Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic.

Authors:  Andrew Santiago-Frangos; Laina N Hall; Anna Nemudraia; Artem Nemudryi; Pushya Krishna; Tanner Wiegand; Royce A Wilkinson; Deann T Snyder; Jodi F Hedges; Calvin Cicha; Helen H Lee; Ava Graham; Mark A Jutila; Matthew P Taylor; Blake Wiedenheft
Journal:  Cell Rep Med       Date:  2021-05-27

Review 7.  Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.

Authors:  Yingjun Li; Nan Peng
Journal:  Front Microbiol       Date:  2019-10-25       Impact factor: 5.640

8.  Structural basis for inhibition of an archaeal CRISPR-Cas type I-D large subunit by an anti-CRISPR protein.

Authors:  M Cemre Manav; Lan B Van; Jinzhong Lin; Anders Fuglsang; Xu Peng; Ditlev E Brodersen
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

9.  Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity.

Authors:  Kawanda Foster; Sabine Grüschow; Scott Bailey; Malcolm F White; Michael P Terns
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

10.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.